-
Cancer patients are at a greater risk for developing diabetes, according to a new study. The study also concludes that cancer patients who develop diabetes die sooner than survivors without […]
Jun 06,2022
-
Preliminary analysis of data from an ongoing investigator-initiated, single-center Phase 1 study supported by BioNTech and Genentech and conducted at Memorial Sloan Kettering Cancer Center, New York, United States. Autogene […]
Jun 06,2022
-
This week, the American Association for Cancer Research (AACR) released its AACR Cancer Disparities Progress Report 2022. According to the report, while overall cancer incidence and mortality rates are declining […]
Jun 10,2022
-
By: Sejin Chung Hi! Iβm Sejin Chung, PhD, the newest member of the Lustgarten Research Team. I was thrilled to represent the Foundation at ASCO22 to share a few key […]
Jul 07,2022
-
President Joe Biden may have a lot of tough work on his plate at home and around the work, but deserves credit this year for trying to take on cancer […]
Aug 09,2022
-
Surveillance programs for people at high risk of developing pancreatic cancers can help detect precancerous conditions and cancers early, when they are most treatable, according to a new multicenter Lustgarten […]
Jul 14,2022
-
Researchers keen to unleash the potential of immunotherapy for pancreatic cancer patients are bringing new drug candidates into the mix, including some that were created for different conditions entirely.
Jul 21,2022
-
According to a new study, substances that are said to boost athletic performance can also activate a receptor that speeds up the development of pancreatic cancer in mice.
Aug 01,2022